StonvexLoading…
StonvexStonvexStonvexCore line items from CXW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.21B | $1.96B | $1.90B | $1.85B |
Operating Income | $157.18M | $91.96M | $95.82M | $165.30M |
Net Income | $116.50M | $68.87M | $67.59M | $122.32M |
EPS (Diluted) | $1.08 | $0.62 | $0.59 | $1.03 |
Total Assets | $3.26B | $2.93B | $3.11B | $3.24B |
Total Liabilities | $1.85B | $1.44B | $1.63B | $1.81B |
Cash & Equivalents | $97.93M | $107.49M | $121.84M | $149.40M |
Free Cash Flow OCF − CapEx | $61.26M | $206.73M | $166.53M | $95.31M |
Shares Outstanding | 100.05M | 109.86M | 112.73M | 114.99M |